Serrated adenomas

Current Gastroenterology Reports

Volumn 11, Issue 5, 2009, Pages 420-427

  Jesus Monge, Wilfredo E ^a   Gonzalez Keelan, Carmen ^a   Cruz Correa, Marcia ^a  

^a UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; QUERCETIN; SULINDAC;

ADENOMATOUS POLYP; ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CARDIOVASCULAR DISEASE; COLON ADENOMA; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; ENDOSCOPIC BIOPSY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; GENE SILENCING; HUMAN; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; ONCOGENE; ONCOGENE BRAF; ONCOGENE K RAS; REVIEW; SERRATED ADENOMATOUS POLYPOSIS; SESSILE SERRATED ADENOMA; STROKE; TRADITIONAL SERRATED ADENOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOMA; BIOPSY; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 70349481610     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0063-x     Document Type: Review

References (46)

1. O'Brien MJ: Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007, 36:947-968.
2. Longacre TA, Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/ serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 1990, 14:524-537.
3. Aaltonen LA, Hamilton SR: World Health Organization, International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Digestive System. Lyon, Oxford: IARC Press; 2000.
4. Torlakovic E, Skovlund E, Snover DC, et al.: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003, 27:65-81.
5. Groff RJ, Nash R, Ahnen DJ: Significance of serrated polyps of the colon. Curr Gastroenterol Rep 2008, 10:490-498.
6. Carr NJ, Mahajan H, Tan KL, et al.: Serrated and non-serrated polyps of the colorectum: Their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009, 62:516-518.
7. Spring KJ, Zhao ZZ, Karamatic R, et al.: High prevalence of sessile serrated adenomas with BRAF mutations: A prospective study of patients undergoing colonoscopy. Gastroenterology 2006, 131:1400-1407.
8. Mansoor I: Clinicopathological analysis of serrated adenomas of the colorectum. Internet Journal of Pathology 2003, 2. Available at http://www.ispub.com/journal/the_internet_journal_of_pathology/ volume_2_number_2_44/article/ clinicopathological_analysis_of_serrated_adenomas_of_the_colorectum.html Accessed July 2009
9. Li SC, Burgart L: Histopathology of serrated adenoma, its variants, and differentiation from conventional adenomatous and hyperplastic polyps. Arch Pathol Lab Med 2007, 131:440-445.
10. Torlakovic EE, Gomez JD, Driman DK, et al.: Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 2008, 32:21-29.
11. Jass JR: GastrointestiCal polyposes: clinical, pathological and molecular features. Gastroenterol Clin North Am 2007, 36:927-946.
12. Torlakovic E, Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 1996, 110:748-755.
13. Sieber OM, Segditsas S, Knudsen AL, et al.: Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 2006, 55:1440-1448.
14. Cruz-Correa M, Giardiello FM: Familial adenomatous polyposis. Gastrointest Endosc 2003, 58:885-894.
15. Matsumoto T, Iida M, Kobori Y, et al.: Serrated adenoma in familial adenomatous polyposis: Relation to germline APC gene mutation. Gut 2002, 50:402-404.
16. Jass JR, Smith M: Sialic acid and epithelial differentiation in colorectal polyps and cancer - a morphological, mucin and lectin histochemical study. Pathology 1992, 24:233-242.
17. Jass JR, Whitehall VL, Young J, Leggett BA: Emerging concepts in colorectal neoplasia. Gastroenterology 2002, 123:862-876.
18. Vogelstein, B, Fearon ER, Hamilton SR, et al.: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532.
19. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP: Serrated polyps of the large intestine: A morphologic and molecular review of an evolving concept. Am J Clin Pathol 2005, 124:380-391.
20. Goldstein NS: Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: A study of eight cases. Am J Clin Pathol 2006, 125:132-145.
21. O'Brien MJ, Yang S, Mack C, et al.: Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006, 30:1491-1501.
22. Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261-268.
23. Kambara T, Simms LA, Whitehall VL, et al.: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004, 53:1137-1144.
24. Minoo P, Baker K, Goswami R, et al.: Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006, 55:1467-1474.
25. Arber N, Levin B: Chemoprevention oT colorectal neoplasia: the potential for personalized medicine. Gastroenterology 2008, 134:1224-1237.
26. Steinbach G, Lynch PM, Phillips RK, et al.: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342:1946-1952.
27. Cruz-Correa M, Hylind LM, Romans KE, et al.: Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study. Gastroenterology 2002, 122:641-645.
28. Bertagnolli MM, Eagle CJ, Zauber AG, et al.: Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006, 355:873-884.
29. Baron JA, Sandler RS, Bresalier RS, et al.: A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006, 131:1674-1682.
30. Cruz-Correa M, Shoskes DA, Sanchez P, et al.: Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2006, 4:1035-1038.
31. Raju R, Cruz-Correa M: Chemoprevention of colorectal cancer. Dis Colon Rectum 2006, 49:113-124.
32. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin, 2009, 59:225-249.
33. Levin B, Lieberman DA, McFarland B, et al.: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570-1595.
34. Pabby A, Schoen RE, Weissfeld JL, et al.: Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005, 61:385-391.
35. Farrar WD, Sawhney MS, Nelson DB, et al.: Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 2006, 4:1259-1264.
36. Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544-560.
37. Matsumoto T, Mizuno M, Shimizu M, et al.: Serrated adenoma of the colorectum: Colonoscopic and histologic features. Gastrointest Endosc 1999, 49:736-742.
38. Rex DK, Bond JH, Winawer S, et al.: Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002, 97:1296-1308.
39. Winawer SJ, Zauber AG, Fletcher RH, et al.: Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006, 130:1872-1885.
40. Chandra A, Sheikh AA, Cerar A, Talbot IC: Clinico-pathological aspects of colorectal serrated adenomas. World J Gastroenterol 2006, 12:2770-2772.
41. Farris AB, Misdraji J, Srivastava A, et al.: Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008, 32:30-35.
42. Kawasaki T, Nosho K, Ohnishi M, et al.: Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer 2008, 8:33.
43. Kim K, Park U, Wang J, et al.: Gene profiling of colonic serrated adenomas by using oligonucleotide microarray. Int J Colorectal Dis 2008, 23:569-580.
44. Owens SR, Chiosea SI, Kuan, SF: Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol 2008, 21:660-669.
45. Li D, Jin C, McCulloch C, et al.: Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol 2009, 104:695-702.
46. Oono Y, Fu K, Nakamura H, et al.: Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009, 54:906-909.